Please find below a press release from
Robust operational performance driving strong results ahead of budget
- EPRA Earnings* amounted to €219.6 million (+21% compared to
31 Dec. 2022 ) or €5.02/share - Rental income increased to €314.2 million (+15% compared to
31 Dec. 2022 ) - 5.2% increase in rental income on a like-for-like basis over the year
- Weighted average unexpired lease term of 19 years and occupancy rate of 100%
Real estate portfolio* of more than €5.8 billion as at
- 617 healthcare properties for approx. 46,900 end users across 8 countries
- Investment programme of €413 million in pre-let development projects and acquisitions in progress, of which €245 million remains to be invested. In 2023, 36 projects were delivered for a total investment budget of approx. €309 million
Solid balance sheet and strong liquidity
- 39.7% debt-to-assets ratio as at
31 December 2023 - Strengthening equity: €406 million raised on capital markets through two capital increases (rights issue & optional dividend)
- New long-term bank financing contracted for €645 million (of which €540 million is refinancing and €105 million is new financing)
- €911 million of headroom on committed credit lines to finance CAPEX and liquidity needs
- BBB investment-grade credit rating with a stable outlook reaffirmed by S&P
Outlook
- Proposed dividend of €3.80/share (gross) is confirmed (distribution in
May 2024 ) - EPRA Earnings* for 2024 are estimated at €223 million, or €4.70/share
UK REIT regime will increase the contribution ofUK operating cashflows to the Group’s results- An increasing dividend of €3.90/share (gross) proposed for the 2024 financial year
Attachments
- Press release EN
- Communiqué de presse FR
Persbericht NL
© OMX, source